Emerging roles of circular RNAs in retinal diseases

Aneliya Hanineva1, Karen Sophia Park1, Joshua J Wang1

  • 1Department of Ophthalmology and Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

Insights

Circular RNAs (ribonucleic acids) show promise as biomarkers and therapeutic targets for retinal disorders. This review explores their emerging roles in conditions like diabetic retinopathy and age-related macular degeneration.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Retinal disorders involve neural and vascular degeneration, with current treatments offering limited success in reversing neuronal damage.
  • Research is shifting towards novel molecular mechanisms underlying retinal disease pathogenesis.
  • Circular RNAs (circRNAs) are a newly identified class of molecules with potential significance in ocular diseases.

Purpose of the Study:

  • To review the emerging roles of circular RNAs in the pathogenesis of common retinal disorders.
  • To explore the potential of circRNAs as biomarkers for disease diagnosis and progression.
  • To investigate circRNAs as novel therapeutic targets for retinal diseases.

Main Methods:

  • Literature review of current research on circular RNAs and retinal diseases.
  • Analysis of studies investigating circRNA function as microRNA modulators and gene transcription regulators.
  • Synthesis of evidence linking circRNAs to specific retinal pathologies.

Main Results:

  • Circular RNAs are implicated in the pathogenesis of diabetic retinopathy, glaucoma, proliferative vitreoretinopathy, and age-related macular degeneration.
  • circRNAs function as crucial modulators of microRNAs and regulators of gene transcription.
  • Emerging evidence highlights circRNAs as potential biomarkers for disease development and progression.

Conclusions:

  • Circular RNAs represent a novel area of research with significant implications for understanding and treating retinal disorders.
  • circRNAs hold promise as diagnostic biomarkers and therapeutic targets for various retinal conditions.
  • Further investigation into circRNA mechanisms is crucial for developing effective interventions.